Daiichi Sankyo (DSNKY) and AstraZeneca’s Enhertu has been approved in the European Union as a monotherapy for the treatment of adult patients with unresectable or metastatic hor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback